3 results on '"Anthony Deny"'
Search Results
2. Familial Transmission of emm12 Group A Streptococcus
- Author
-
Anthony Deny, F. Giraud, A. Vachée, Claire Duployez, Frédéric Wallet, Olivier Robineau, Caroline Loïez, Eric Senneville, CHU Lille, CNRS, Inserm, Institut Pasteur de Lille, Université de Lille, Centre Hospitalier Régional Universitaire [Lille] [CHRU Lille], METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694, Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS], Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL], Centre Hospitalier de Roubaix, Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre Hospitalier de Tourcoing, Centre de Référence des Infections Ostéo-Articulaires Complexes Nord-Ouest (CRIOAC-Lille-Tourcoing), Hôpital Roger Salengro [Lille]-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre Hospitalier Gustave Dron [Tourcoing], Dr. Duployez works as a microbiological fellow in the microbiology department of the University Hospital of Lille, We thank the staff of the Centre National de Référence des Streptocoques and C. Poyart for their assistance in characterization of the group A streptococcal isolates., National Institute for Health Research, and Université de Lille, LillOA
- Subjects
Male ,Letter ,Epidemiology ,medicine.medical_treatment ,Streptococcal infections ,MESH: Streptococcal Infections/drug therapy ,MESH: Streptococcal Infections/microbiology ,0302 clinical medicine ,1108 Medical Microbiology ,MESH: Fasciitis, Necrotizing/drug therapy ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,MESH: Streptococcus pyogenes/growth & development ,Medicine ,MESH: Anti-Bacterial Agents/therapeutic use ,Streptococcus ,Group A Streptococcus ,familial ,Streptococci ,3. Good health ,1117 Public Health And Health Services ,Microbiology (medical) ,medicine.medical_specialty ,amoxicillin-clavulanic acid ,MESH: Amoxicillin-Potassium Clavulanate Combination/therapeutic use ,030106 microbiology ,MESH: Bursitis/pathology ,MESH: Disease Transmission, Infectious ,Amoxicillin-Potassium Clavulanate Combination ,Microbiology ,lcsh:Infectious and parasitic diseases ,03 medical and health sciences ,Research Letter ,Disease Transmission, Infectious ,MESH: Streptococcal Infections/transmission ,Humans ,Fasciitis, Necrotizing ,Post-exposure prophylaxis ,Spouses ,MESH: Streptococcal Infections/pathology ,Aged ,MESH: Humans ,Bacteria ,Public health ,lcsh:R ,Familial transmission ,antibacterial ,polymorphonuclear ,chemistry ,Immunology ,Linezolid ,invasive ,MESH: Female ,0301 basic medicine ,Pediatrics ,NSAIDs ,Familial Transmission of emm12 Group A Streptococcus ,MESH: Fasciitis, Necrotizing/pathology ,lcsh:Medicine ,medicine.disease_cause ,Group A ,chemistry.chemical_compound ,antibiotic ,030212 general & internal medicine ,MESH: Aged ,MESH: Fasciitis, Necrotizing/microbiology ,MESH: Streptococcus pyogenes/pathogenicity ,Transmission (medicine) ,Incidence (epidemiology) ,Anti-Inflammatory Agents, Non-Steroidal ,Anti-Bacterial Agents ,Infectious Diseases ,MESH: Bursitis/microbiology ,[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,MESH: Streptococcus pyogenes/drug effects ,Female ,iGAS ,group A streptococcal infections ,leukocyte ,STREPTOCOCCAL INFECTIONS ,procalcitonin ,medicine.drug ,MESH: Contraindications, Drug ,Streptococcus pyogenes ,MESH: Anti-Inflammatory Agents, Non-Steroidal/adverse effects ,Secondary infection ,linezolid ,C-reactive ,emm12 ,Bursitis ,030225 pediatrics ,MESH: Spouses ,antimicrobial drug ,lcsh:RC109-216 ,Letters to the Editor ,nonsteroidal anti-inflammatory drugs ,Amoxicillin/clavulanic acid ,business.industry ,Contraindications, Drug ,1103 Clinical Sciences ,MESH: Male ,MESH: Bursitis/drug therapy ,business - Abstract
Comment in : Familial Transmission of emm12 Group A Streptococcus. [Emerg Infect Dis. 2018]; International audience; Incidence and severity of invasive group A Streptococcus infections are of increasing concern in France and worldwide. The risk for secondary infection of close contacts is known but rarely described. We report a case of intrafamilial and life-threatening transmission of emm12 group A Streptococcus.
- Published
- 2018
- Full Text
- View/download PDF
3. Can patients return to high-impact physical activities after hip resurfacing? A prospective study
- Author
-
Henri Migaud, Nicolas Fouilleron, Julien Girard, Anthony Deny, and Bruno Miletic
- Subjects
musculoskeletal diseases ,Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Arthroplasty, Replacement, Hip ,Treatment outcome ,Motor Activity ,medicine ,Humans ,Orthopedics and Sports Medicine ,Prospective Studies ,Sports activity ,Prospective cohort study ,Original Paper ,business.industry ,Incidence ,Follow up studies ,Recovery of Function ,Middle Aged ,Arthroplasty ,Hip resurfacing ,Arthralgia ,Treatment Outcome ,Orthopedic surgery ,Physical therapy ,Surgery ,Female ,Hip Joint ,Hip Prosthesis ,business ,human activities ,Total hip arthroplasty ,Follow-Up Studies ,Sports - Abstract
Although the resumption of low-impact sports activities is compatible with total hip arthroplasty (THA), participation in high-impact sports seems problematic, and there is no consensus as to whether it is advisable. The purpose of this article is to evaluate the quality and possibility of resuming high-impact physical activities after hip resurfacing.The study was performed in an on-going, single-surgeon, prospective series of 215 resurfacing arthroplasties (RSA). Mean follow-up was 44.1 months (range, 39.1-54.5). Clinical evaluation included the Postel-Merle d'Aubigné (PMA) score, the Oxford hip score, the Harris hip score (HHS), Devane score, and UCLA activity score. A specific questionnaire analysing sports activities was administered to each patient to assess the number and level of physical activities performed (both before the operation and at final follow-up).In the series of 202 consecutive patients (215 RSA), 50 patients (55 RSA) engaged regularly in at least one high-impact activity before their operation and the onset of pain, 102 patients practised at least one intermediate-impact activity, and the 50 remaining patients undertook only low-impact activities. Harris hip score increased from 44.8 (range, 23-68) before the operation to 97.8 (range, 85-100) at the last follow-up. Mean time to sports resumption after surgery was 14.6 weeks (range, 7-29). The resumption rate was 98 % for sports of any impact level and 82 % for high-impact activities. No osteolysis or implant loosening was observed at follow-up. No revision was performed.In 2012, no consensus recommendations yet exist for the resumption of sports activities after RSA. Existing recommendations concern only conventional THA. We believe that RSA allows younger and more active patients to resume physical and sports activities without restriction. The rate of return to sports after RSA appears to be excellent and unequalled by conventional hip prostheses. High-impact sports seem to be compatible with hip resurfacing, although no long-term studies have analysed the impact of these activities on wear and/or aseptic loosening.
- Published
- 2013
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.